Transvaginal Mesh Lawsuits
Complications that have been reported by transvaginal mesh patients include pain, bleeding, infection, organ perforation, erosion through the vagina and urinary problems. Mesh erosion is the most common problem associated with transvaginal mesh, and in some cases cannot be fixed. Some women might also experience pain during intercourse and emotional problems.
The FDA also noted that many cases of POP can be treated without using surgical mesh, and that surgeons should carefully weigh the risks and the benefits for each individual patient.
Women with POP, who have been treated with surgical mesh, might be eligible to file a transvaginal mesh lawsuit if they have suffered serious complications following surgery. Our attorneys are reviewing potential lawsuits for women nationwide and would like to help you.
We believe that you should be compensated for your pain, suffering and debilitating injuries. If you would like to speak with a lawyer in a free and confidential consultation, please contact us today. We will listen to your story and let you know how we can help you.
Call today to schedule a free review of your case.
Transvaginal Mesh Complications
Transvaginal mesh has been linked to serious injuries and complications in a number of patients. In fact, the public advocacy group Public Citizen urged the U.S. Food and Drug Administration (FDA) to ban the use of all transvaginal mesh products that are used to treat pelvic organ prolapse (POP) on Aug. 25, 2011.
POP is a condition that occurs in approximately 30 to 50 percent of women after childbirth. The stress of childbirth can weaken the muscles and tissue that surround organs such as the uterus, bladder, bowel and top of the vagina.
When the supporting tissue and muscles are weakened, the organs can bulge or prolapse into the vagina or in some cases, beyond the wall of the vagina. POP has been treated surgically for years. In 2002, the FDA approved the use of surgical mesh to reinforce the tissue after surgically reinforcing the organs back into place.
The FDA issued a safety communication on July 13, 2011 to notify health care providers that the serious complications associated with surgical mesh to treat POP are "not rare." According to the agency, it has received 1,503 reports of complications with surgical mesh in POP patients from Jan. 1, 2008 to Dec. 31, 2010.